placeholder
Importance
38
Trust
71
Urgency
30
COMMERCIAL
STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
More employers plan to stop paying for GLP-1 weight-loss drugs next year as more people use them. The article covers employer coverage decisions and mentions a Sanofi setback, but full details aren't available in this excerpt.
Analysis
More employers may stop covering GLP-1 weight-loss drugs. That could mean higher out-of-pocket costs for patients who use Ozempic or Wegovy.
- More employers plan to stop paying for GLP-1 weight-loss drugs next year
- Drop in employer coverage linked to rising number of people using the drugs
STAT News9d
Read